METHODOLOGICAL CHALLENGES OF COST-OF-ILLNESS STUDIES ON DEMENTIA- AN INTERNATIONAL SYSTEMATIC REVIEW
Author(s)
Schaller SU*1;Mauskopf JA2;Kriza C1;Wahlster P1, Kolominsky-Rabas PL1 1Centre for Health Technology Assessment (HTA) and Public Health (IZPH), University of Erlangen-Nuremberg, Erlangen, Germany, 2RTI Health Solutions, Research Triangle Park, NC, USA
OBJECTIVES: Increasing prevalence of dementia highlights the need for a better understanding of the cost burden for health policy makers. By descriptive analysis of specific cost impacts, cost-of-illness (COI) studies are an essential instrument for decision making and planning of health care services. Therefore the purpose of this study was to review COI studies of dementia in order to analyze cost components and underlying methods in an international context. METHODS: A systematic review according to the PRISMA-guidelines was conducted from 2002-2012 in order to identify COI studies related to dementia, searching the PubMed, Cochrane, EMBASE and NHS Economics Evaluations databases. Annual outcomes per patients were analyzed for total, direct, indirect and informal costs. RESULTS: In total 25 studies were evaluated. Total costs showed an annual range from USD 3.512 to USD 59.526 in 14 health care systems. This is due to the fact, that the composition of cost components and corresponding methods indicated a large heterogeneity in terms of both – study characteristics (e.g. diagnosis, care setting, disease stratification) and composition of cost components. The majority of studies (92%, n=23) included direct costs, however different cost components and underlying measurements were applied. Almost two thirds (60%, n=15) of the studies included informal costs, whereas 9 used the replacement cost approach and 6 studies the opportunity cost approach. CONCLUSIONS: Outcomes of COI studies in dementia indicate a large range, due to differences in health care systems, but also because of methodological approaches and cost components included. Dementia as a long-lasting and progressive disease affects multiple cost dimensions and thereby poses a complex challenge for policy makers. In addition, international guidelines on cost analysis of dementia are lacking. Standards regarding the methodology of COI studies in dementia by the scientific community would be useful. Funded by the European Commission, ICT-FP7, project-ID-287509.
Conference/Value in Health Info
2013-11, ISPOR Europe 2013, The Convention Centre Dublin
Value in Health, Vol. 16, No. 7 (November 2013)
Code
PMH22
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Mental Health, Neurological Disorders